Biblioteca Humberto Rosselli Quijano
Journal of Clinical Psychopharmacology / Rothschild, Anthony J. . Año 2009 - Vol. 29 - No. 2Mención de fecha: Abril Fecha de aparición: 26/10/2022 |
[número]
[número]
Año 2009 - Vol. 29 - No. 2 - Abril - Journal of Clínical Psychopharmacology [texto impreso] / Anthony J. Rothschild, Autor . - 2022 . - pp. 105-199 : Cuadros, gráficas ; 28 cm. ISSN : 0271-0749 Idioma : Inglés (eng) Idioma original : Inglés (eng) |
Ejemplares (1)
Código de barras | Signatura | Tipo de medio | Ubicación | Sección | Estado |
---|---|---|---|---|---|
100079 | Journal of Clinical Psychopharmacology | Publicaciones seriadas | Biblioteca Instituto Colombiano del Sistema Nervioso | Hemeroteca | Disponible |
Artículos
Añadir el resultado a su cestaHormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions / Astrid B. Birkenaes en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions Tipo de documento: texto impreso Autores: Astrid B. Birkenaes, Autor ; Kåre I. Birkeland, Autor ; Svein Friis, Autor Fecha de publicación: 2022 Artículo en la página: pp. 109-116 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Insulina, Leptina, Adiponectina, SHBG, Cortisol Resumen: Dyslipidemia independent of body mass has previously been reported in humans after antipsychotic treatment. The present study investigated the levels of several metabolic regulatory hormones in psychiatric outpatients treated with different antipsychotics under real-life conditions. Link: ./index.php?lvl=notice_display&id=29512
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 109-116[artículo] Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions [texto impreso] / Astrid B. Birkenaes, Autor ; Kåre I. Birkeland, Autor ; Svein Friis, Autor . - 2022 . - pp. 109-116.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 109-116
Palabras clave: Antipsicóticos, Insulina, Leptina, Adiponectina, SHBG, Cortisol Resumen: Dyslipidemia independent of body mass has previously been reported in humans after antipsychotic treatment. The present study investigated the levels of several metabolic regulatory hormones in psychiatric outpatients treated with different antipsychotics under real-life conditions. Link: ./index.php?lvl=notice_display&id=29512 Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls / Yong Min Ahn en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls Tipo de documento: texto impreso Autores: Yong Min Ahn, Autor ; Kyu Young Lee, Autor ; Chul Eung Kim, Autor Fecha de publicación: 2022 Artículo en la página: pp. 117-123 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Amisulprida, Pacientes con esquizofrenia, Función neurocognitiva, Control saludable, Efecto de la práctica Resumen: We examined short- and long-term changes in neurocognitive functions in patients with schizophrenia who were either started or switched to amisulpride in comparison with the normal controls. Fifty-seven patients treated with amisulpride and 60 normal controls completed a comprehensive neurocognitive function test battery at the baseline, the 8-week, and the 1-year follow-up. Link: ./index.php?lvl=notice_display&id=29514
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 117-123[artículo] Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls [texto impreso] / Yong Min Ahn, Autor ; Kyu Young Lee, Autor ; Chul Eung Kim, Autor . - 2022 . - pp. 117-123.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 117-123
Palabras clave: Amisulprida, Pacientes con esquizofrenia, Función neurocognitiva, Control saludable, Efecto de la práctica Resumen: We examined short- and long-term changes in neurocognitive functions in patients with schizophrenia who were either started or switched to amisulpride in comparison with the normal controls. Fifty-seven patients treated with amisulpride and 60 normal controls completed a comprehensive neurocognitive function test battery at the baseline, the 8-week, and the 1-year follow-up. Link: ./index.php?lvl=notice_display&id=29514 Acute and chronic effects of ketamine on semantic priming / Ana Stefanovic en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Acute and chronic effects of ketamine on semantic priming : Modeling schizophrenia? Tipo de documento: texto impreso Autores: Ana Stefanovic, Autor ; Brigitta Brandner, Autor ; Elissa Klaassen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 124-133 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ketamina, Esquizofrenia, Cebado semántico, Receptor NMDA, Hipofunción de glutamato Resumen: Acute administration of the N-methyl-d-aspartate receptor antagonist ketamine induces schizophrenia-like symptoms in healthy volunteers; furthermore, a window on ketamine's chronic effects is provided by regular recreational users. Link: ./index.php?lvl=notice_display&id=29515
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 124-133[artículo] Acute and chronic effects of ketamine on semantic priming : Modeling schizophrenia? [texto impreso] / Ana Stefanovic, Autor ; Brigitta Brandner, Autor ; Elissa Klaassen, Autor . - 2022 . - pp. 124-133.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 124-133
Palabras clave: Ketamina, Esquizofrenia, Cebado semántico, Receptor NMDA, Hipofunción de glutamato Resumen: Acute administration of the N-methyl-d-aspartate receptor antagonist ketamine induces schizophrenia-like symptoms in healthy volunteers; furthermore, a window on ketamine's chronic effects is provided by regular recreational users. Link: ./index.php?lvl=notice_display&id=29515 Lithium, antipsychotics, and risk of psoriasis / Yolanda B. Brauchli en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Lithium, antipsychotics, and risk of psoriasis Tipo de documento: texto impreso Autores: Yolanda B. Brauchli, Autor ; Susan S. Jick, Autor ; François Curtin, Autor Fecha de publicación: 2022 Artículo en la página: pp. 134-140 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Litio, Antipsicóticos, Psoriasis, Danzapina, Estudio de casos y controles Resumen: Observations in controlled trials and case reports have linked lithium exposure to induction or exacerbation of psoriasis. A causal relationship between lithium exposure and incident psoriasis has been questioned, and observational studies are lacking. Link: ./index.php?lvl=notice_display&id=29516
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 134-140[artículo] Lithium, antipsychotics, and risk of psoriasis [texto impreso] / Yolanda B. Brauchli, Autor ; Susan S. Jick, Autor ; François Curtin, Autor . - 2022 . - pp. 134-140.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 134-140
Palabras clave: Litio, Antipsicóticos, Psoriasis, Danzapina, Estudio de casos y controles Resumen: Observations in controlled trials and case reports have linked lithium exposure to induction or exacerbation of psoriasis. A causal relationship between lithium exposure and incident psoriasis has been questioned, and observational studies are lacking. Link: ./index.php?lvl=notice_display&id=29516 Systematic overview of cochrane reviews for anticholinergic effects of antipsychotic drugs / Mehmet Ozbilen en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Systematic overview of cochrane reviews for anticholinergic effects of antipsychotic drugs Tipo de documento: texto impreso Autores: Mehmet Ozbilen, Autor ; Clive Adams, Autor Fecha de publicación: 2022 Artículo en la página: pp. 141-146 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Efectos anticolinérgicos, Ensayos, Fármacos antipsicóticos, Visión borrosa, Sequedad de boca, Estreñimiento Resumen: Despite much being written on the topic, there are few surveys investigating the prevalence of anticholinergic adverse effects of antipsychotic drugs. One study, however, used trial-derived data to calculate estimates. Link: ./index.php?lvl=notice_display&id=29517
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 141-146[artículo] Systematic overview of cochrane reviews for anticholinergic effects of antipsychotic drugs [texto impreso] / Mehmet Ozbilen, Autor ; Clive Adams, Autor . - 2022 . - pp. 141-146.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 141-146
Palabras clave: Esquizofrenia, Efectos anticolinérgicos, Ensayos, Fármacos antipsicóticos, Visión borrosa, Sequedad de boca, Estreñimiento Resumen: Despite much being written on the topic, there are few surveys investigating the prevalence of anticholinergic adverse effects of antipsychotic drugs. One study, however, used trial-derived data to calculate estimates. Link: ./index.php?lvl=notice_display&id=29517 Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease / Arun L.W. Bokde en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study Tipo de documento: texto impreso Autores: Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor Fecha de publicación: 2022 Artículo en la página: pp. 147-156 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer Resumen: Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients. Link: ./index.php?lvl=notice_display&id=29518
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156[artículo] Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study [texto impreso] / Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor . - 2022 . - pp. 147-156.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156
Palabras clave: Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer Resumen: Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients. Link: ./index.php?lvl=notice_display&id=29518 Sexual dysfunction, depression, and the impact of antidepressants / Sidney H. Kennedy en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Sexual dysfunction, depression, and the impact of antidepressants Tipo de documento: texto impreso Autores: Sidney H. Kennedy, Autor ; Sakina Rizvi, Autor Fecha de publicación: 2022 Artículo en la página: pp. 157-164 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Disfunción sexual, ISRS, Antidepresivos, Trastorno depresivo mayor, Agomelatina Resumen: Sexual dysfunction is a common symptom of depression. Although decreased libido is most often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile dysfunction in men, and absent or delayed orgasm are also prevalent. Sexual dysfunction is also a frequent adverse effect of treatment with most antidepressants and is one of the predominant reasons for premature drug discontinuation. Link: ./index.php?lvl=notice_display&id=29519
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 157-164[artículo] Sexual dysfunction, depression, and the impact of antidepressants [texto impreso] / Sidney H. Kennedy, Autor ; Sakina Rizvi, Autor . - 2022 . - pp. 157-164.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 157-164
Palabras clave: Disfunción sexual, ISRS, Antidepresivos, Trastorno depresivo mayor, Agomelatina Resumen: Sexual dysfunction is a common symptom of depression. Although decreased libido is most often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile dysfunction in men, and absent or delayed orgasm are also prevalent. Sexual dysfunction is also a frequent adverse effect of treatment with most antidepressants and is one of the predominant reasons for premature drug discontinuation. Link: ./index.php?lvl=notice_display&id=29519